Medtronic Faces Removal Of CoreValve Transcatheter Heart Valve From German Market

In the wake of a major patent decision, Medtronic will be forced to remove its CoreValve transcatheter heart valve from the German market. Edwards Lifesciences said today that a German Court had found that Medtronic infringed a key patent, known as the Spenser patent, and granted an injunction prohibiting the sale of CoreValve and CoreValve Evolut systems in Germany.

Medtronic said it would appeal the decision and said the action “will limit options for physicians and their patients who need transcatheter aortic valve procedures, which Medtronic believes is contrary to sound health policy.”

Click here to read the full post on Forbes.

I

Leave a Reply

%d bloggers like this: